Atricure Stock Performance
| ATRC Stock | USD 36.80 1.27 3.34% |
On a scale of 0 to 100, AtriCure holds a performance score of 7. The firm shows a Beta (market volatility) of 1.46, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, AtriCure will likely underperform. Please check AtriCure's treynor ratio, kurtosis, relative strength index, as well as the relationship between the downside variance and day median price , to make a quick decision on whether AtriCure's price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in AtriCure are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, AtriCure exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (3.34) | Five Day Return (0.41) | Year To Date Return (6.29) | Ten Year Return 117.24 | All Time Return 161.36 |
1 | AtriCure Is Down 5.8 percent After Raising Revenue Guidance and Narrowing Net Loss Has The Bull Case Changed | 11/10/2025 |
2 | Disposition of 5033 shares by Wehrwein Sven of AtriCure at 19.95 subject to Rule 16b-3 | 11/24/2025 |
3 | Justin Noznesky Sells 5,166 Shares of AtriCure Stock | 11/28/2025 |
4 | Disposition of 4000 shares by Michael Carrel of AtriCure subject to Rule 16b-3 | 12/10/2025 |
5 | How supply chain issues affect AtriCure Inc. stock - Market Risk Report Fast ExitEntry Strategy Plans - | 12/18/2025 |
6 | Acquisition by Douglas Seith of 257 shares of AtriCure at 27.37 subject to Rule 16b-3 | 12/31/2025 |
7 | Head to Head Survey Hero Technologies vs. AtriCure | 01/05/2026 |
8 | AtriCure stock hits 52-week high at 43.18 - Investing.com | 01/08/2026 |
9 | AtriCure Reports Strong Preliminary 2025 Revenue Growth - The Globe and Mail | 01/13/2026 |
10 | Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results | 01/16/2026 |
11 | AtriCure Is Up 5.1 percent After Raising 2026 Guidance And Refinancing Credit Facility - Has The Bull Case Changed | 01/22/2026 |
12 | ISRGs da Vinci Gets FDA Nod for Advanced Cardiac Procedures | 01/27/2026 |
13 | QT Imaging Olea Medical Partner to Enhance Cloud Imaging Platform | 01/28/2026 |
14 | Cencora Stock Down Despite Q1 Earnings Beat, Gross Margin Improves | 02/04/2026 |
| Begin Period Cash Flow | 84.3 M | |
| Total Cashflows From Investing Activities | 30.2 M |
AtriCure Relative Risk vs. Return Landscape
If you would invest 3,150 in AtriCure on November 6, 2025 and sell it today you would earn a total of 530.00 from holding AtriCure or generate 16.83% return on investment over 90 days. AtriCure is currently generating 0.3072% in daily expected returns and assumes 3.2652% risk (volatility on return distribution) over the 90 days horizon. In different words, 29% of stocks are less volatile than AtriCure, and 94% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
AtriCure Target Price Odds to finish over Current Price
The tendency of AtriCure Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 36.80 | 90 days | 36.80 | about 60.44 |
Based on a normal probability distribution, the odds of AtriCure to move above the current price in 90 days from now is about 60.44 (This AtriCure probability density function shows the probability of AtriCure Stock to fall within a particular range of prices over 90 days) .
AtriCure Price Density |
| Price |
Predictive Modules for AtriCure
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AtriCure. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.AtriCure Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. AtriCure is not an exception. The market had few large corrections towards the AtriCure's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold AtriCure, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of AtriCure within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.08 | |
β | Beta against Dow Jones | 1.46 | |
σ | Overall volatility | 3.21 | |
Ir | Information ratio | 0.03 |
AtriCure Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AtriCure for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AtriCure can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| AtriCure had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 465.31 M. Net Loss for the year was (44.7 M) with profit before overhead, payroll, taxes, and interest of 388.06 M. | |
| AtriCure has a frail financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Azenta director Alan P. Malus resigns from board for new full-time role - Investing.com |
AtriCure Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of AtriCure Stock often depends not only on the future outlook of the current and potential AtriCure's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AtriCure's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 47 M | |
| Cash And Short Term Investments | 122.7 M |
AtriCure Fundamentals Growth
AtriCure Stock prices reflect investors' perceptions of the future prospects and financial health of AtriCure, and AtriCure fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AtriCure Stock performance.
| Return On Equity | -0.0611 | ||||
| Return On Asset | -0.0265 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 1.76 B | ||||
| Shares Outstanding | 49.72 M | ||||
| Price To Earning | 33.47 X | ||||
| Price To Book | 3.97 X | ||||
| Price To Sales | 3.53 X | ||||
| Revenue | 465.31 M | ||||
| Gross Profit | 388.06 M | ||||
| EBITDA | (18.53 M) | ||||
| Net Income | (44.7 M) | ||||
| Cash And Equivalents | 118.45 M | ||||
| Cash Per Share | 2.55 X | ||||
| Total Debt | 76.53 M | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 3.66 X | ||||
| Book Value Per Share | 9.59 X | ||||
| Cash Flow From Operations | 12.2 M | ||||
| Earnings Per Share | (0.59) X | ||||
| Market Capitalization | 1.83 B | ||||
| Total Asset | 609.33 M | ||||
| Retained Earnings | (401.75 M) | ||||
| Working Capital | 194.4 M | ||||
| Current Asset | 74.75 M | ||||
| Current Liabilities | 31.59 M | ||||
About AtriCure Performance
By analyzing AtriCure's fundamental ratios, stakeholders can gain valuable insights into AtriCure's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AtriCure has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AtriCure has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 210.11 | 133.18 | |
| Return On Tangible Assets | (0.14) | (0.13) | |
| Return On Capital Employed | (0.07) | (0.07) | |
| Return On Assets | (0.07) | (0.07) | |
| Return On Equity | (0.09) | (0.09) |
Things to note about AtriCure performance evaluation
Checking the ongoing alerts about AtriCure for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AtriCure help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AtriCure had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 465.31 M. Net Loss for the year was (44.7 M) with profit before overhead, payroll, taxes, and interest of 388.06 M. | |
| AtriCure has a frail financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Azenta director Alan P. Malus resigns from board for new full-time role - Investing.com |
- Analyzing AtriCure's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AtriCure's stock is overvalued or undervalued compared to its peers.
- Examining AtriCure's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AtriCure's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AtriCure's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AtriCure's stock. These opinions can provide insight into AtriCure's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for AtriCure Stock analysis
When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |